Allergy and Immunology · Hershey, PA
NPI
1609825306
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 University Dr
Hershey, PA, 17033
Phone (800) 243-1455
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,788
216 services
Medicare patients, 2024
92
Average age 70
Drug cost, 2024
$4.3M
567 prescriptions
Company payments, 2025
$100K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy J Craig was code 99214 (office e&m - established), 51 times for 50 patients. In total Timothy J Craig billed 216 services in 11 codes, and Medicare paid $7,788.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 51 | 50 | $62.74 | $3,200 |
| 94010 Pulmonary Function Testing | Facility | 26 | 24 | $5.78 | $150 |
| 99215 Office E&M - Established | Facility | 17 | 16 | $88.18 | $1,499 |
| 99213 Office E&M - Established | Facility | 16 | 15 | $46.90 | $750 |
| 99204 Office E&M - New | Facility | 12 | 12 | $92.10 | $1,105 |
By year: 2022 $11K for 511 services; 2023 $8,555 for 275 services; 2024 $7,788 for 216 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy J Craig prescribed most often to Medicare patients was Prolastin C (Alpha-1-Proteinase Inhibitor), with 47 prescriptions and refills. In total Timothy J Craig wrote 567 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prolastin C Alpha-1-Proteinase Inhibitor | 47 | 47 | Under 11 | $519K |
| Fluticasone Propionate Generic | 42 | 66 | 14 | $509 |
| Breo Ellipta Fluticasone/Vilanterol | 41 | 51 | Under 11 | $20K |
| Montelukast Sodium Generic | 37 | 77 | 13 | $1,026 |
| Takhzyro Lanadelumab-Flyo | 37 | 37 | Under 11 | $1.8M |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 31 | 35 | Under 11 | $4,316 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 30 | 30 | Under 11 | $193K |
| Azelastine Hcl Generic | 24 | 35 | Under 11 | $516 |
| Epinephrine Generic | 18 | 20 | 16 | $4,640 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 | 21 | Under 11 | $410 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 14 | 26 | Under 11 | $17K |
| Glassia Alpha-1-Proteinase Inhibitor | 14 | 14 | Under 11 | $261K |
| Azithromycin Generic | 14 | 14 | Under 11 | $185 |
| Omeprazole Generic | 12 | 18 | Under 11 | $245 |
| Levocetirizine Dihydrochloride Generic | 11 | 27 | Under 11 | $1,281 |
Brand drugs: 327 claims; generic drugs: 240 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy J Craig $100K ($100K in general payments such as food, travel and fees) from 15 companies. The largest payer was CSL Behring with $65K.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 59 | $65K |
| BioCryst US Sales Co., LLC | 7 | $11K |
| Ionis Pharmaceuticals, Inc. IONS | 8 | $11K |
| Insmed, Inc. INSM | 19 | $5,164 |
| Grifols USA, LLC | 4 | $4,039 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,582 |
| Hexal AG | 1 | $1,013 |
| Pharming Healthcare, Inc. | 4 | $757 |
| Genzyme Corporation SNY | 4 | $350 |
| BioCryst Pharmaceuticals, Inc. BCRX | 5 | $220 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.